2018

Creation of the second ABL entity in France through the acquisition of the Accinov innovative platform in Lyon

2016

Creation of the first ABL entity in France through the acquisition of the Transgene production asset in Strasbourg* * Expansion of ABL capabilities through the viral vector manufacturing plant, certified GMP in 1995.

2014

ABL acquires Platine Pharma in Lyon and built GCLP testing labs

2011

ABL opens Rockville, MD headquarters

2004

ABL spun out from bioMérieux as a sister company, under Institut Mérieux

2001

ABL acquired by bioMérieux. ABL becomes an Institut Mérieux Company

1985

Organon Teknika acquires R&D and diagnostic assets, renames company ABL

1968

Acquired by Litton Industries. Expanded activities in retrovirus and cancer research

1961

Bionetics Research Laboratory was established